Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.59 |
| ▸ | MAOB | P27338 | 1/20 | 0.59 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.52 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | SHMT2 | P34897 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31151882 | 1.00 | MAOA (0.59) | MAOAMAOBABCC4PTGS1GAA | |
| SCHEMBL2760383 | 0.80 | ABCC4 (0.59) | MAOAMAOBABCC4PTGS1LMNA | |
| SCHEMBL651524 | 0.80 | MAOB (0.44) | MAOAMAOBABCC4PTGS1LMNA | |
| SCHEMBL8106789 | 0.80 | ABCC4 (0.43) | MAOAMAOBABCC4PTGS1 | |
| SCHEMBL7789411 | 0.80 | ABCC4 (0.46) | MAOAMAOBABCC4PTGS1LMNA | |
| SCHEMBL22472604 | 0.79 | MAOA (0.52) | MAOAMAOBABCC4PTGS1GAA | |
| SCHEMBL813060 | 0.77 | MAOA (0.59) | MAOAMAOBABCC4PTGS1GAA | |
| SCHEMBL29588358 | 0.77 | MAOA (0.59) | MAOAMAOBABCC4PTGS1GAA | |
| SCHEMBL7022937 | 0.77 | ABCC4 (0.37) | MAOAMAOBABCC4PTGS1GAA | |
| SCHEMBL10812388 | 0.77 | MAOA (0.53) | MAOAMAOBABCC4PTGS1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118345390-A | Method for preparing carbonyl compound by electrocatalytic oxidation of benzyl C-H bond by pyridine nitrogen oxide | 浙江大学 | 2024-07-16 | — | — | CN | claimed |
| CN-113121550-B | Preparation method of 7-ethoxycarbonyl-5H-benzopyran [2,3-b ] pyridine-5-ketone | 武汉先路医药科技股份有限公司 | 2024-04-02 | — | — | CN | claimed |
| CN-113121550-A | Preparation method of 7-ethoxycarbonyl-5H-benzopyran [2,3-b ] pyridine-5-ketone | 武汉先路医药科技股份有限公司 | 2021-07-16 | — | — | CN | claimed |
| EP-0991793-B1 | METHOD FOR PREPARING 2-ARYL OR 2-HETEROCYCLYL CHIRAL PROPIONIC ACIDS AND THEIR ESTERS | CT NAT DE BR LA RECH SCIENT (FR) | 2001-12-05 | — | — | EP | claimed |
| US-6294069-B1 | MIXTURE OF PROPIONIC ACID DERIVATIVE IS ELECTROCHEMICALLY REDUCED IN THE PRESENCE OF NICKEL COMPLEX CATALYST AND SUPPORTING ELECTROLYTE IN ELECTROLYSIS CELL PROVIDED WITH ELECTRODES, PRODUCT IS HYDROLYZED OR TRANSESTERIFIED | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2001-09-25 | — | — | US | claimed |
| EP-0485173-A2 | Esters and amides of substituted fused ring phenyl acetic acids | FGN, INC. (US) | 1992-05-13 | — | — | EP | claimed |
| JP-4095094-A | — | — | None | — | — | JP | disclosed |
| JP-4288080-A | — | — | None | — | — | JP | disclosed |
| CN-119661548-A | Pranoprofen Process for the preparation of intermediates | 辰欣药业股份有限公司 | 2025-03-21 | — | — | CN | disclosed |
| US-20240343738-A1 | Method for preparing pranoprofen and composition comprising pranoprofen and impurity | SHENYANG XINGQI PHARMACEUTICAL CO., LTD. (CN) | 2024-10-17 | — | — | US | disclosed |
| CN-118345390-A | Method for preparing carbonyl compound by electrocatalytic oxidation of benzyl C-H bond by pyridine nitrogen oxide | 浙江大学 | 2024-07-16 | — | — | CN | disclosed |
| CN-113845427-B | Aryl alcohol, aryl ketone, aryl carboxylic acid compound, and synthetic method and application thereof | 华东师范大学 | 2024-06-25 | — | — | CN | disclosed |
| EP-4361155-A1 | METHOD FOR PREPARING PRANOPROFEN AND COMPOSITION CONTAINING PRANOPROFEN AND IMPURITY | Shenyang Xingqi Pharmaceutical Co., Ltd. (CN) | 2024-05-01 | — | — | EP | disclosed |
| EP-0828702-A1 | PROCESS FOR RESOLVING CHIRAL ACIDS WITH 1-AMINOINDAN-2-OLS | SEPRACOR, INC. (US) | 1998-03-18 | — | — | EP | disclosed |
| WO-1996036584-A1 | PROCESS FOR RESOLVING CHIRAL ACIDS WITH 1-AMINOINDAN-2-OLS | SEPRACOR, INC. (US) | 1996-11-21 | — | — | WO | disclosed |
| JP-H04288080-A | PRODUCTION OF BENZOPYRANO(2,3-B)PYRIDINE DERIVATIVE | YODOGAWA SEIYAKU KK | 1992-10-13 | — | — | JP | disclosed |
| EP-0485173-A2 | Esters and amides of substituted fused ring phenyl acetic acids | FGN, INC. (US) | 1992-05-13 | — | — | EP | disclosed |
| JP-H0495094-A | SYNTHESIS OF BENZOPYRANO(2,3-B)PYRIDINE DERIVATIVE | YODOGAWA SEIYAKU KK | 1992-03-27 | — | — | JP | disclosed |
| US-3931205-A | ANTIRHEUMATIC, ANTIINFLAMMATORY, ANALGESIC, ANTIPYRETIC | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JA) | 1976-01-06 | — | — | US | disclosed |
| US-3931199-A | ANTIALLERGY | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JA) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240343738-A1 | Method for preparing pranoprofen and composition comprising pranoprofen and impurity | CYP3A5, CYP3A43, CYP4A11 | MAOA 1014/4885MAOB 637/4885ABCC4 3340/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.